Cost-Effectiveness Evaluation of Linezolid, Vancomycin and Teicoplanin in Treating Nosocomial Pneumonia Caused by Methicilin Resistant Staphylococcus Aureus (Mrsa) – Private Health Care System Perspective
Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.411
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2013
Authors
Publisher
Elsevier BV